What is the primary purpose of non-invasive respiratory support in neonates?

What is the primary purpose of non-invasive respiratory support in neonates?

• A. Maintain functional residual capacity, stabilize the chest wall, improve lung compliance, decrease work of breathing, and improve oxygenation
• B. Increase FiO2 to 100% immediately
• C. Replace need for monitoring and medical therapy
• D. Cure chronic lung disease

Answer: (A)

The main idea is that non-invasive respiratory support provides gentle positive pressure to keep the tiny airways and alveoli open, which helps the lungs work more efficiently without needing intubation. By delivering continuous positive airway pressure, it maintains functional residual capacity, helps stabilize the chest wall, improves lung compliance, reduces the energy the baby must expend to breathe, and enhances oxygenation. This approach supports the infant’s breathing while minimizing risks associated with invasive ventilation. It’s not about forcing oxygen to 100% right away—the goal is to achieve adequate oxygenation with the lowest possible FiO2 and to titrate support as the baby improves. It does not replace ongoing monitoring and medical therapies (such as treatment for infection or surfactant when indicated). And it is not a cure for chronic lung disease; it’s a supportive measure to help the neonate breathe more easily as the lungs mature.

The main idea is that non-invasive respiratory support provides gentle positive pressure to keep the tiny airways and alveoli open, which helps the lungs work more efficiently without needing intubation. By delivering continuous positive airway pressure, it maintains functional residual capacity, helps stabilize the chest wall, improves lung compliance, reduces the energy the baby must expend to breathe, and enhances oxygenation. This approach supports the infant’s breathing while minimizing risks associated with invasive ventilation.

It’s not about forcing oxygen to 100% right away—the goal is to achieve adequate oxygenation with the lowest possible FiO2 and to titrate support as the baby improves. It does not replace ongoing monitoring and medical therapies (such as treatment for infection or surfactant when indicated). And it is not a cure for chronic lung disease; it’s a supportive measure to help the neonate breathe more easily as the lungs mature.